Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
593
datasets available to search
ShareScore release 0.9.0
Dataset results
593 results for “Anxiety Disorders”
Generalized Anxiety Disorder Adjunct Study
ClinicalTrials.gov study NCT00534599. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Memantine Treatment for Obsessive-compulsive Disorder and Generalized Anxiety Disorder
ClinicalTrials.gov study NCT00674219. IPD Sharing: NO. Countries: 1. Publications: 1.
Transdiagnostic CBT for Comorbid Alcohol Use and Anxiety Disorders
ClinicalTrials.gov study NCT03230006. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Ketamine Infusion for Social Anxiety Disorder
ClinicalTrials.gov study NCT02083926. IPD Sharing: NO. Countries: 1. Publications: 6.
Parent-based Treatment for Youth With Anxiety and Obsessive-compulsive Disorder
ClinicalTrials.gov study NCT04922502. IPD Sharing: NO. Countries: 1. Publications: 1.
Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder
ClinicalTrials.gov study NCT01491035. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder
ClinicalTrials.gov study NCT02066792. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents
ClinicalTrials.gov study NCT01177969. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder
ClinicalTrials.gov study NCT00730691. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults.
ClinicalTrials.gov study NCT00744627. IPD Sharing: Not stated. Countries: 8. Publications: 2.
Primary Care Intervention Strategy for Anxiety Disorders
ClinicalTrials.gov study NCT00347269. IPD Sharing: YES. Countries: 1. Publications: 35.
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
ClinicalTrials.gov study NCT00616655. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Comparison Between Cognitive, Behavioral, and Cognitive-Behavioral Therapy for Generalized Anxiety Disorder
ClinicalTrials.gov study NCT00635999. IPD Sharing: NO. Countries: 1. Publications: 10.
PREVALENCE OF ALCOHOL USE, DEPRESSIVE AND ANXIETY DISORDERS AMONG PATIENTS OF OPIOID AGONIST TREATMENT PROGRAMMES IN UKRAINE
<p>Prevalence data collection was organised based on Opioid Assisted Treatment centres in three Ukrainian cities, Kyiv (one centre, centre of Ukraine), Sumy (one centre, east), and Lviv (one centre, west), during the period from October 2021 to January 2022 (before the full-scale Russian invasion). </p><p>The staff of OAT centres did all the data collection. Doctors, psychologists, or social workers who previously obtained detailed instructions made individual screenings for medication during patients' appointed visits. All the questionaries (AUDIT for alcohol use patterns, PHQ-9 for depression symptoms, GAD-7 for anxiety symptoms) were printed out in the Ukrainian language and filled in together with each patient. In addition, the number of missed visits on site for substitute medication for the last month was counted, and blood alcohol levels were recorded with the breath-alcohol measuring instrument (Drager Alcotest 6820). </p><p>The dataset is based on the results of the program of the Global Fund to Fight AIDS, Tuberculosis and Malaria, "Accelerating Progress in Reducing the Burden of Tuberculosis and HIV Infection in Ukraine", in accordance with the Grant Agreement between the Public Health Center of Ministry of Health of Ukraine and the Global Fund to Fight AIDS, Tuberculosis and Malaria No. 1936 of December 04, 2020. The donor was not involved in the study design, the collection, analysis and interpretation of data or the preparation of the article.</p>
Cost-effectiveness of preventative care for perinatal anxiety and associated disorders: A rapid review
<p><strong>Objectives: </strong>Perinatal mental health (PMH) problems affect one in five women and cost the United Kingdom (UK) £8.1 billion for every year of births, with 72% of this cost due to the long-term impact on the child. We conducted a rapid review of health economic evaluations of preventative care for perinatal anxiety and associated disorders.</p> <p><strong>Design: </strong>This study adopted a rapid review approach, using principles of the standard systematic review process to generate quality evidence. This methodology features a systematic database search, PRISMA diagram, screening of evidence, data extraction, critical appraisal, and narrative synthesis.</p> <p><strong>Data Sources: </strong>PubMed, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Cochrane Library, <em>Applied Social Sciences Index and Abstracts</em> (ASSIA), PsycINFO and MEDLINE.</p> <p><strong>Eligibility criteria for selecting studies: </strong>Studies that evaluated the costs and cost-effectiveness of preventative care for perinatal anxiety and associated disorders carried out within the National Health Service (NHS) and similar healthcare systems.</p> <p><strong>Data extraction and synthesis:</strong> A minimum of two independent reviewers used standardised methods to search, screen, critically appraise and synthesise included studies.</p> <p><strong>Results: </strong>The results indicate a lack of economic evaluation specifically for perinatal anxiety, with most studies focussing on postnatal depression (PND). Interventions to prevent postnatal mental health problems are cost-effective. Modelling studies have also been conducted, which suggest that treating PND with counselling would be cost-effective.</p> <p><strong>Conclusion:</strong> The costs of not intervening in maternal mental health outweigh the costs of preventative interventions. Preventative measures such as screening and counselling for maternal mental health are shown to be cost-effective interventions to improve outcomes for women and children.</p> <p><strong>PROSPERO registration number: </strong>CRD42022347859</p>
Comorbid-phenome prediction and phenotype risk scores enhance gene discovery for generalized anxiety disorder and posttraumatic stress disorder
<p>GWAS summary statistics. See ReadMe for column descriptions.</p>
A brief online transdiagnostic measure: psychometric properties of the Overall Anxiety Severity and Impairment Scale (OASIS) among Spanish patients with emotional disorders
<p>This dataset contains demographic and clinical data about 583 patients with anxiety and depressive disorders that participated in a study whose objective is to examine the psychometric properties of the online version of the Overall Anxiety Severity and Impairment Scale in Spanish clinical population. </p>
Sleep Related Breathing Disorders, Anxiety, Depression and Quality of Life Assessment in Behcet's Disease
ClinicalTrials.gov study NCT05142995. IPD Sharing: NO. Countries: 1. Publications: 3.
Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder
ClinicalTrials.gov study NCT00122863. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder
ClinicalTrials.gov study NCT00329446. IPD Sharing: Not stated. Countries: 1. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.